Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID R CAMIDGE

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1336239912
CMS profile
241703
Location
AURORA, CO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$72,784.57

33 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
Daiichi Sankyo Inc. $18,431.25 3
Takeda Pharmaceuticals U.S.A., Inc. $15,900.00 5
GENZYME CORPORATION $5,788.99 2
AstraZeneca Pharmaceuticals LP $5,137.00 2
ABBVIE INC. $4,500.14 2
Amgen Inc. $3,894.00 2
Janssen Biotech, Inc. $3,720.00 2
Regeneron Pharmaceuticals, Inc. $2,718.09 3
Regeneron Healthcare Solutions, Inc. $2,292.50 1
AstraZeneca UK Limited $2,055.00 1
PFIZER INC. $1,907.60 3
Coherus Biosciences Inc. $1,800.00 2
BeiGene Switzerland GmbH $1,300.00 1
BeiGene USA, Inc. $1,300.00 1
BeiGene, Ltd. $1,300.00 1
Janssen Global Services, LLC $540.00 1
Novocure GmbH $200.00 1

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

33 matching records · $72,784.57 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 33 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–33 of 33.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Biotech, Inc. $1,860.0012/22/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026964348087 CMS
Amgen Inc. $2,596.0012/16/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026939886847 CMS
Amgen Inc. $1,298.0012/16/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026939886849 CMS
AstraZeneca Pharmaceuticals LP $1,712.0012/07/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914792097 CMS
Coherus Biosciences Inc. $900.0012/01/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026956563369 CMS
GENZYME CORPORATION $88.9911/28/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026938987181 CMS
AstraZeneca UK Limited $2,055.0011/14/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915389883 CMS
Daiichi Sankyo Inc. $1,712.5010/26/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026930889219 CMS
Janssen Biotech, Inc. $1,860.0010/21/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026885608983 CMS
Janssen Global Services, LLC $540.0010/15/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026887126749 CMS
GENZYME CORPORATION $5,700.0009/29/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026938987177 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,400.0009/12/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026955603215 CMS
BeiGene USA, Inc. $1,300.0009/07/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026940789967 CMS
Takeda Pharmaceuticals U.S.A., Inc. $900.0009/04/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026955603213 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6,300.0008/30/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026955603211 CMS
Takeda Pharmaceuticals U.S.A., Inc. $900.0008/25/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026955603209 CMS
PFIZER INC. $11.7507/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026949492771 CMS
Daiichi Sankyo Inc. $7,812.5007/12/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026930888609 CMS
Regeneron Pharmaceuticals, Inc. $2,620.0007/08/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026927739219 CMS
PFIZER INC. $1,825.0006/27/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026949158677 CMS
Regeneron Pharmaceuticals, Inc. $8.5906/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026927739209 CMS
Regeneron Pharmaceuticals, Inc. $89.5006/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026927739213 CMS
PFIZER INC. $70.8506/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026949655889 CMS
ABBVIE INC. $100.1406/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026890699677 CMS
BeiGene Switzerland GmbH $1,300.0005/19/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026940798933 CMS
BeiGene, Ltd. $1,300.0005/11/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026940789969 CMS
Daiichi Sankyo Inc. $8,906.2505/09/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026930888379 CMS
AstraZeneca Pharmaceuticals LP $3,425.0005/03/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915295867 CMS
Takeda Pharmaceuticals U.S.A., Inc. $5,400.0004/04/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026955603207 CMS
Coherus Biosciences Inc. $900.0003/23/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026956563361 CMS
Regeneron Healthcare Solutions, Inc. $2,292.5002/11/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026927121861 CMS
Novocure GmbH $200.0001/19/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026950529877 CMS
ABBVIE INC. $4,400.0001/07/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026890699675 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $97,234.92 64
PY2020 $142,330.66 61
PY2021 $116,180.25 39
PY2022 $72,784.57 33
PY2023 $76,051.25 40
PY2024 $70,256.00 54
PY2025 $72,775.05 43

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
DAVID R CAMIDGE, NPI 1336239912. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1336239912.
APA 7
IndustryPayments. (2026). DAVID R CAMIDGE, NPI 1336239912 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1336239912
Bluebook
DAVID R CAMIDGE, NPI 1336239912, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1336239912.

Source: Centers for Medicare & Medicaid Services, Open Payments.